Stay updated on Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedVersion history shows a new revision entry (v3.4.2) and the removal of a government funding notice. These updates are limited to site governance and do not alter the study record data or its substantive content.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and status updates; updated the page revision to v3.4.1, replacing the previous v3.4.0 entry.SummaryDifference0.5%

- Check28 days agoChange DetectedShow glossary is now available in the history view, and additions/deletions are color-coded with green and red highlights, respectively, plus explanatory text about the color-coding.SummaryDifference1.0%

- Check42 days agoChange DetectedAdded revision entry: v3.3.4 to the record history and removed v3.3.3. This is an update to the page's version history entries.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision v3.3.3 added; HHS Vulnerability Disclosure and Revision v3.3.2 removed.SummaryDifference0.1%

- Check92 days agoChange DetectedThe record history now includes a new revision entry (v3.3.2) replacing the previous revision (v3.2.0). There are no changes to study details or status.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.